EA
ORIC icon

Emerald Advisers’s Oric Pharmaceuticals ORIC Stock Holding History

Emerald Advisers’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-726,236
Closed -$15.2M – 290
2021
Q3 		$15.2M Buy
726,236
+123,478
+20% +$2.5M 0.55% 75
2021
Q2 		$10.7M Sell
602,758
-12,753
-2% -$279K 0.39% 96
2021
Q1 		$15.1M Buy
615,511
+93,209
+18% +$2.95M 0.54% 84
2020
Q4 		$17.7M Buy
522,302
+197,720
+61% +$5.67M 0.59% 76
2020
Q3 		$8.12M Buy
324,582
+138,442
+74% +$3.29M 0.33% 97
2020
Q2 		$6.28M Buy
+186,140
New +$5.94M 0.27% 109

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Emerald Advisers's ORIC Position: Q4 2021 in Review

Emerald Advisers sold out of Oric Pharmaceuticals (ORIC) in Q4 2021, closing a stake of 726,236 shares — an estimated $15.2M sold.

Emerald Advisers first reported a position in ORIC in Q2 2020 and held it in 6 quarters. The position peaked at $17.7M in Q4 2020. 80 funds tracked by Wall St. Rank hold ORIC as of Q4 2021.

  • Emerald Advisers reported no remaining Oric Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Emerald Advisers sold 726,236 Oric Pharmaceuticals shares in Q4 2021, an estimated $15.2M.
  • Emerald Advisers first reported a position in Oric Pharmaceuticals in Q2 2020 and held it in 6 quarters.
  • Emerald Advisers's Oric Pharmaceuticals position peaked at $17.7M in Q4 2020.
  • 80 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q4 2021.

Based on Emerald Advisers's 13F filing for Q4 2021, filed 2 Feb 2022.